Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (101-110 of 974) with videos related to

Pageof 98
Sort By:
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 7, 2009
Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancerGeorg Pfeiler, Oliver Treeck, Gitte Wenzel, et al.
Molecular Cancer|November 8, 2008
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerJürgen Veeck, Erik Noetzel, Nuran Bektas, et al.
Breast Care (Basel, Switzerland)|December 3, 2011
Invasive Breast Cancer: Recognition of Molecular SubtypesJohanna D Strehl, David L Wachter, Peter A Fasching, et al.
International Journal of Clinical and Experimental Pathology|February 2, 2012
Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GISTAbbas Agaimy, Nikolaos Vassos, Peter H Wunsch, et al.
Human Pathology|December 20, 2005
Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinomaArndt Hartmann, Kerstin Junker, Wolfgang Dietmaier, et al.
Urologia Internationalis|January 11, 2023
Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical TrialsChristian Bolenz, Frank Kunath, Friedemann Zengerling, et al.
BJU International|April 26, 2008
Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?Maximilian Burger, Stefan Denzinger, Wolf-Ferdinand Wieland, et al.
Medical Oncology (Northwood, London, England)|December 31, 2016
c-Met in chromophobe renal cell carcinomaFranziska Erlmeier, Philipp Ivanyi, Arndt Hartmann, et al.
Carcinogenesis|March 22, 2008
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosisJürgen Veeck, Cordelia Geisler, Erik Noetzel, et al.
Breast Cancer Research : BCR|January 10, 2008
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patientsAndrea Sassen, Justine Rochon, Peter Wild, et al.
Pageof 98

Showing results (101-110 of 974) with videos related to

Sort By:
Pageof 98
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 7, 2009
Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancerGeorg Pfeiler, Oliver Treeck, Gitte Wenzel, et al.
Molecular Cancer|November 8, 2008
Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancerJürgen Veeck, Erik Noetzel, Nuran Bektas, et al.
Breast Care (Basel, Switzerland)|December 3, 2011
Invasive Breast Cancer: Recognition of Molecular SubtypesJohanna D Strehl, David L Wachter, Peter A Fasching, et al.
International Journal of Clinical and Experimental Pathology|February 2, 2012
Impact of serosal involvement/extramural growth on the risk of synchronous and metachronous peritoneal spread in gastrointestinal stromal tumors: proposal for a macroscopic classification of GISTAbbas Agaimy, Nikolaos Vassos, Peter H Wunsch, et al.
Human Pathology|December 20, 2005
Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinomaArndt Hartmann, Kerstin Junker, Wolfgang Dietmaier, et al.
Urologia Internationalis|January 11, 2023
Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical TrialsChristian Bolenz, Frank Kunath, Friedemann Zengerling, et al.
BJU International|April 26, 2008
Does the current World Health Organization classification predict the outcome better in patients with noninvasive bladder cancer of early or regular onset?Maximilian Burger, Stefan Denzinger, Wolf-Ferdinand Wieland, et al.
Medical Oncology (Northwood, London, England)|December 31, 2016
c-Met in chromophobe renal cell carcinomaFranziska Erlmeier, Philipp Ivanyi, Arndt Hartmann, et al.
Carcinogenesis|March 22, 2008
Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosisJürgen Veeck, Cordelia Geisler, Erik Noetzel, et al.
Breast Cancer Research : BCR|January 10, 2008
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patientsAndrea Sassen, Justine Rochon, Peter Wild, et al.
Pageof 98